| Literature DB >> 19788913 |
Jeffery N Talbot1, Donald A Skifter, Elisabetta Bianchi, Daniel T Monaghan, Myron L Toews, L Charles Murrin.
Abstract
Mu opioid receptors (MOP) are transducers of the pharmacological effects of many opioid drugs, including analgesia and tolerance/dependence. Previously, we observed increased MOP signaling during postnatal development that was not associated with increased MOP or G protein expression. A yeast two-hybrid screen of a human brain cDNA library using the MOP C-terminus as bait identified RanBPM as a potential MOP-interacting protein. RanBPM has been recognized as a multi-functional scaffold protein that interacts with a variety of signaling receptors/proteins. Co-immunoprecipitation studies in HEK293 cells indicated that RanBPM constitutively associates with MOP. Functionally, RanBPM had no effect on MOP-mediated inhibition of adenylyl cyclase, yet reduced agonist-induced endocytosis of MOP. Mechanistically, RanBPM interfered with beta arrestin2-GFP translocation stimulated by MOP but not alpha(1B)-adrenergic receptor activation, indicating selectivity of action. Our findings suggest that RanBPM is a novel MOP-interacting protein that negatively regulates receptor internalization without altering MOP signaling through adenylyl cyclase.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19788913 PMCID: PMC2783972 DOI: 10.1016/j.neulet.2009.09.048
Source DB: PubMed Journal: Neurosci Lett ISSN: 0304-3940 Impact factor: 3.046